Personality-Based Therapy for Borderline Personality Disorder
Trial Summary
The trial does not specify if you need to stop taking your current medications, but it mentions 'medication instability' as an exclusion criterion, which might mean your medication needs to be stable before joining.
Research shows that therapies like Dialectical Behavior Therapy (DBT) and Mentalization-Based Therapy (MBT) are effective for treating Borderline Personality Disorder, helping improve emotional regulation and interpersonal relationships.
12345Personality-Based Therapy, including Dialectical Behavior Therapy (DBT) and Mentalization-Based Therapy (MBT), is widely used and considered safe for treating borderline personality disorder. These therapies are evidence-based and have been implemented in various settings, indicating their general safety in humans.
16789Personality-Based Therapy for borderline personality disorder is unique because it combines several evidence-based treatments like Dialectical Behavior Therapy (DBT) and Mentalization-Based Therapy (MBT), which focus on improving emotional regulation and understanding others' perspectives. This approach is distinct in its comprehensive integration of multiple therapeutic techniques tailored to individual needs, unlike standard treatments that may focus on a single method.
1581011Eligibility Criteria
This trial is for English-speaking individuals diagnosed with Borderline Personality Disorder. It's not suitable for those who have other psychological conditions needing different treatments, are currently in psychotherapy, have substance use disorders, or whose medication use isn't stable.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants undergo a 2-4 week baseline assessment to determine level of outcomes of interest in the absence of treatment
Treatment
Participants receive six weekly 50-60-minute treatment sessions tailored to 1 of 3 personality dimensions
Follow-up
Participants are monitored for sustainability of the treatment module after the treatment sessions
Participant Groups
Personality-Based Therapy is already approved in United States, European Union, Canada for the following indications:
- Borderline Personality Disorder
- Borderline Personality Disorder
- Borderline Personality Disorder